Vigonvita Life Sciences

This early-stage study tested the safety and how the body handles a new drug called LV232. It involved 81 healthy Chinese volunteers who received either the drug or a placebo. The goal was to check for side effects and measure drug levels in the blood, not to treat any disease.

This study looked at how two different forms of an experimental drug (deuterium deuremidevir) are absorbed by the body. It involved 18 healthy Chinese adults who took each version once, with a break in between. The goal was to measure drug levels in the blood, not to treat any di…

This study tested the safety and how the body handles a new drug called LV232 in 49 healthy Chinese volunteers. Participants took multiple doses of the drug, and researchers measured how it moved through the body and checked for side effects. This is an early-stage study with no …